{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"pancreatic-endocrine-carcinoma","columns":[{"gene":"","key":"population-ef9745ec5e7b2bcf98de","label":"pancreatic endocrine carcinoma","mondoId":"MONDO:0005893","onsetQualifier":null,"originColumnKey":"MONDO:0005893/no-native-evidence","originalViews":[{"key":"MONDO:0005893/no-native-evidence","label":"pancreatic endocrine carcinoma","scopeLabel":"No safely mapped HPO entry","sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"recordKeys":[],"recordQualifiers":{},"scopeLabel":"No safely mapped HPO entry","sourceIds":[],"sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-ef9745ec5e7b2bcf98de"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":["population-ef9745ec5e7b2bcf98de"],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the pancreas. The mitotic count is more than 20 per 10 HPF. According to the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm, it is classified either as small or large cell neuroendocrine carcinoma.","mondoId":"MONDO:0005893","node":{"canonicalSlug":"pancreatic-endocrine-carcinoma","comparisons":[{"documentSha256":"ac034b8d569a1fbd8d9e7e80afac01b025c9b84359db84f8361d76256ef1012d","key":"expanded-digestive-system-neuroendocrine-neoplasm","kind":"expanded","label":"digestive system neuroendocrine neoplasm","memberIds":["MONDO:0000386","MONDO:0000540","MONDO:0002563","MONDO:0002882","MONDO:0002883","MONDO:0002993","MONDO:0002994","MONDO:0002995","MONDO:0003111","MONDO:0003504","MONDO:0003523","MONDO:0003524","MONDO:0003525","MONDO:0003621","MONDO:0003622","MONDO:0003646","MONDO:0003649","MONDO:0003708","MONDO:0003978","MONDO:0004116","MONDO:0004117","MONDO:0004210","MONDO:0004211","MONDO:0004236","MONDO:0004252","MONDO:0004333","MONDO:0004334","MONDO:0004377","MONDO:0004411","MONDO:0005048","MONDO:0005815","MONDO:0005893","MONDO:0006091","MONDO:0006093","MONDO:0006126","MONDO:0006155","MONDO:0006162","MONDO:0006219","MONDO:0006227","MONDO:0006229","MONDO:0006250","MONDO:0006257","MONDO:0006347","MONDO:0006348","MONDO:0006405","MONDO:0006976","MONDO:0015062","MONDO:0015063","MONDO:0015064","MONDO:0015065","MONDO:0015066","MONDO:0015067","MONDO:0015068","MONDO:0015069","MONDO:0015072","MONDO:0015073","MONDO:0018016","MONDO:0018017","MONDO:0018510","MONDO:0018698","MONDO:0018742","MONDO:0019954","MONDO:0019955","MONDO:0019957","MONDO:0019959","MONDO:0019960","MONDO:0021101","MONDO:0021533","MONDO:0021534","MONDO:0021535","MONDO:0023206","MONDO:0024500","MONDO:0024501","MONDO:0024502","MONDO:0024503","MONDO:0024504","MONDO:0024638","MONDO:0024639","MONDO:0024642","MONDO:0024677"],"mondoId":"MONDO:0024503","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-ac034b8d569a1fbd8d9e.ac034b8d569a1fbd8d9e7e80afac01b025c9b84359db84f8361d76256ef1012d.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"pancreatic endocrine carcinoma","paragraphs":["An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the pancreas. The mitotic count is more than 20 per 10 HPF. According to the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm, it is classified either as small or large cell neuroendocrine carcinoma."],"scope":"exact","source":"MONDO","upstream":"NCIT:C3770","url":"https://monarchinitiative.org/MONDO:0005893"},"ownColumnKeys":["population-ef9745ec5e7b2bcf98de"],"publication":"published","relationships":[{"kind":"parent","label":"neuroendocrine carcinoma","mondoId":"MONDO:0002120","slug":"neuroendocrine-carcinoma"},{"kind":"parent","label":"pancreatic neuroendocrine neoplasm","mondoId":"MONDO:0005815","slug":"pancreatic-neuroendocrine-neoplasm"},{"kind":"parent","label":"digestive system carcinoma","mondoId":"MONDO:0006181","slug":null},{"kind":"parent","label":"malignant pancreatic neoplasm","mondoId":"MONDO:0009831","slug":null},{"kind":"child","label":"pancreatic large cell neuroendocrine carcinoma","mondoId":"MONDO:0006347","slug":"pancreatic-large-cell-neuroendocrine-carcinoma"},{"kind":"child","label":"pancreatic small cell neuroendocrine carcinoma","mondoId":"MONDO:0006348","slug":"pancreatic-small-cell-neuroendocrine-carcinoma"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/22056"}],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0005893\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>NCIT:C3770</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the pancreas. The mitotic count is more than 20 per 10 HPF. According to the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm, it is classified either as small or large cell neuroendocrine carcinoma.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0005893\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"pancreatic-endocrine-carcinoma","sourceDocuments":[{"name":"MONDO: pancreatic endocrine carcinoma","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0005893"}],"sourceNote":"","synonyms":["carcinoma of endocrine pancreas","carcinoma, islet cell, malignant","endocrine pancreas carcinoma","high grade pancreatic neuroendocrine carcinoma","high-grade pancreatic neuroendocrine carcinoma","islet cell cancer","islet cell carcinoma","islet cell carcinoma (morphologic abnormality)","malignant islet cell tumor","malignant islet cell tumour","malignant neoplasm of islets of Langerhans","malignant pancreatic endocrine tumor","malignant pancreatic endocrine tumour","pancreatic endocrine cancer","pancreatic endocrine carcinoma","pancreatic NEC","pancreatic NEC G3","Pancreatic Neuroendocrine cancer","pancreatic neuroendocrine carcinoma","poorly differentiated pancreatic endocrine carcinoma","poorly-differentiated NEN of pancreas","poorly-differentiated neuroendocrine neoplasm of pancreas","poorly-differentiated pancreatic NEN","poorly-differentiated pancreatic neuroendocrine neoplasm"],"takeawayHtml":"","title":"pancreatic endocrine carcinoma"},"schemaVersion":1}
